Previous Page  6 / 16 Next Page
Information
Show Menu
Previous Page 6 / 16 Next Page
Page Background

Page 18

Volume 05

Journal of Infectious Diseases and Treatment

ISSN: 2472-1093

JOINT EVENT

Applied Microbiology-2019 & Antibiotics 2019

Immunology 2019

October 21-22, 2019

October 21-22, 2019 Rome, Italy

&

&

8

th

Edition of International Conference on

Antibiotics, Antimicrobials & Resistance

12

th

International Conference on

Allergy & Immunology

6

th

World Congress and Expo on

Applied Microbiology

Hospital-acquired infections in Ukraine

Yulian Konechnyi, Andrij Albokrinov

and

Olena Korniychuk

Danylo Halytsky Lviv National Medical University, Ukraine

Introduction

: According to WHO, approximately 15.0% of all hospitalized patients suffer from Hospital-Acquired

Infection (HAIs). Data from USA and Europe show 1,3% to 2,03% cases of HAIs in hospitalized patients. In

Ukraine -5-7.000 proven cases of HAIs and 500.000 unregistered cases per year. One of the methods to prevent HAIs

is control strategy in Intensive care unit (ICU), where last-line antibiotics are currently used.

Objective

: To define spectrum of microbial flora and antimicrobial sensitivity of HAIs in some ICU in Lviv city,

Ukraine.

Methods

: It was investigated 124 clinical materials from 60 patients at the public hospitals in Lviv during

July 2018 - May 2019. Were isolated 144 strains of pathogenes. HAIs was defined as infection that appeared in

patient later than 48 hours after hospital admission. Causative bacterial strains were isolated and identified

using bacteriological method (Mueller Hinton Agar, Blood Agar, Saburo Agar, selective & differential media

CHROMID*VRE, CHROMID*MRSA SMART, CHROMID*Candida etc. (Biomerieux)) and biochemical tests

MIKRO-LA-TEST NEFERMtest24, CANDIDAtest21, STAPHYtest24 etc. (ErbaLacema). Antibiotic sensitivity test

was done according to Kirby-Bauer technique.

Results

: HAIs structure was as follows:

Staphylpcoccus lentus

(17.7%),

Eschrichia coli

(20.2%),

Klebsiella pneumoniae

(9,7%),

Pseudomonas aeruginosa

(24.2%),

Streptococcus spp

. (2.4%),

MRSA

(3,2%),

Candida albicans

(8.1%).

There were several types of HAIs which are rarely founded, such as

Staph.simulans, Staphylococcus gallinarum

,

Staphylococcus haemolyticus Staphylococcus lugdunensis, Aerococcus viridans

,

Pragia fontium, Aeromonas ichthiosmia,

Raoultella terrigena, Burkholderia pseudomallei, Macrococcus caseolyticus, Pseudomonas oryzihabitans, Pseudomonas

putida, Candida dubliniensis, Candida membranifaciens, Candida glabrata

. Anti-microbial sensitivity assessment

showed that more than 90.0 % pathogens were multidrug resistance (MDR). 75% of strains were atypical strains

(T-index ≥ 0,25).

Conclusion

: In the era of antibiotics HAIs are still uncontrollable. Most cases of HAIs in Ukraine are not recognized

as epidemics. More than 90.0 % pathogens are MDR and most of them are atypical strains. Diagnostic capabilities

show a number of rare species of microorganisms that cause nosocomial infections. It is important to use this fact

when one attempts to design prevention or control strategy to reduce HAIs either at WHO level, or at the level of

local health care unit.

Acknowledgement

: We thank directors of the hospitals and ICU teams.

Ethical Committee

: 25/06/2018 № 6.

Biography

Yulian Konechnyi is doing his PhD in microbiology at Danylo Halytsky Lviv National Medical University, Ukraine. He has completed his MD and have specialization

in internal medicine. He has worked as lecturer at the department of microbioly in microbiology, virusology and immunology topics, at Danylo Halytsky Lviv

National Medical University, Ukraine. He has published 10 different papers.

Yulian Konechnyi et al., J Infec Dis Treat 2019, Volume: 05